ArticleJournal of evaluation in clinical practice2025
Improving Guideline Development Processes: Integrating Evidence Estimation and Decision-Analytical Frameworks.
Article in Journal of evaluation in clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Applications and challenges of biomarker-based predictive models in proactive health management.Frontiers in public health · 2025Pooled it
- Linking Minimally Important Differences (MID) and Acceptable Regret to Elicit Values and Preferences in Health Decision Models.Journal of evaluation in clinical practice · 2026Article
- How to determine the optimal duration of anticoagulation for VTE: an evidence-based decision-analytical approach.Blood advances · 2026Article
- Converting Evidence-Based Summary of Findings Evidence Tables Into Decision Analytical, Quality Adjusted Life Years (QALY) and Life Expectancies Metrics: A Tutorial.Journal of evaluation in clinical practice · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RATIONALE, AIMS AND
objectivesDespite using state-of-the-art methodologies like Grades of Recommendation, Assessment, Development and Evaluation (GRADE), current guideline development frameworks still rely heavily on panellists' intuitive integration of evidence related to the benefits and harms/burdens of health interventions. This leads to the 'black-box' and 'integration' problems, highlighting the lack of transparency in guideline decision-making. Combined with humans' limited capacity to process the large volumes of information presented in Summary of Findings (SoF) tables-the primary output of systematic reviews that underpin guideline recommendations-this reliance on non-explicit processes raises concerns about the trustworthiness of clinical practice guidelines.
methodsSoF tables provide the best available evidence, derived from frequentist or Bayesian estimation frameworks. Decision analysis, which integrates both types of estimates but considers intervention consequences, is the only analytical approach that combines multiple outcomes (benefits, harms and costs) into a single metric to support decision-making. Such analysis seeks to identify the optimal decision by balancing harms, benefits and uncertainties. This paper leverages the PICO format (Population, Intervention, Comparison(s), Outcome) as a conceptual basis for deriving SoF tables. Subsequently, we propose a solution to GRADE's "black-box" and "integration" problems by matching PICO-based SoF with decision models.
resultsWe succeeded in connecting the PICO framework to simple decision-analytical models, restricted to time frames supported by empirically verifiable evidence, to calculate which competing intervention offers the greatest benefit (net differences in expected utility; ΔEU). The single metric [ΔEU] enabled a simple, transparent and easy-to-understand assessment of the superiority of competing management strategies across multiple outcomes (considering both benefits and harms), addressing the 'black-box' and 'integration' problems. Completing a SoF-based decision model takes about 10 min. Not surprisingly, the recommendations based on ΔEU may differ from the intuitive recommendations of panels.
conclusionWe propose that incorporating the straightforward and transparent modelling into guideline panels' decision-making processes will enhance their intuitive judgements, resulting in more trustworthy recommendations. Given the simplicity of calculating ΔEU, we advocate for its immediate inclusion in systematic reviews and SoF tables.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.